NCT01106716View on ClinicalTrials.gov

Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions
Postherpetic Neuralgia
Interventions
DRUG

Placebo

Placebo IV Infusion

DRUG

KAI-1678

KAI-1678 IV Infusion

DRUG

Lidocaine

Lidocaine

Trial Locations (1)

Unknown

Sydney

Sponsors
All Listed Sponsors
collaborator

Trident Clinical Research Pty Ltd

INDUSTRY

lead

KAI Pharmaceuticals

INDUSTRY

NCT01106716 - Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia | Biotech Hunter | Biotech Hunter